{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:11:21Z","timestamp":1784193081410,"version":"3.55.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,13]]},"DOI":"10.1097\/qad.0b013e32835c54b8","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T08:53:05Z","timestamp":1353401585000},"page":"781-785","source":"Crossref","is-referenced-by-count":21,"title":["Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa"],"prefix":"10.1097","volume":"27","author":[{"given":"Megan","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Chersich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Moultrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Fairlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/AAC.00434-08","article-title":"Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.","volume":"52","author":"Saitoh","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy.","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"R8-11-20210130","first-page":"929","article-title":"Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy.","volume":"95","author":"Eshun-Wilson","year":"2005","journal-title":"S Afr Med J"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/QAD.0b013e3282ffb0fd","article-title":"Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy.","volume":"22","author":"Smith","year":"2008","journal-title":"AIDS"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e318033ffa1","article-title":"Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.","volume":"44","author":"Forna","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e318158c0a6","article-title":"Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy.","volume":"46","author":"Mutimura","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/108729104322994810","article-title":"Severe lactic acidosis in association with reverse transcriptase inhibitors with potential response to L-carnitine in a pediatric HIV-positive patient.","volume":"18","author":"Carter","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","article-title":"Lipodystrophy syndrome in human immunodeficiency virus-infected children.","volume":"21","author":"Amaya","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/00002030-200307040-00020","article-title":"Lactate levels in children with HIVAIDS on highly active antiretroviral therapy.","volume":"17","author":"Desai","year":"2003","journal-title":"AIDS"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.PCC.0000090017.86282.78","article-title":"Fatal lactic acidosis during antiretroviral therapy.","volume":"4","author":"Rey","year":"2003","journal-title":"Pediatr Crit Care Med"},{"key":"R17-11-20210130","first-page":"1051","article-title":"Lactic acidosis in HIV infected children due to antiretroviral therapy.","volume":"42","author":"Shah","year":"2005","journal-title":"Indian Pediatr"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.","volume":"1","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children.","volume":"14","author":"Jaquet","year":"2000","journal-title":"AIDS"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-3476(05)80431-7","article-title":"Pancreatitis in pediatric human immunodeficiency virus infection.","volume":"120","author":"Miller","year":"1992","journal-title":"J Pediatr"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/tropej\/fmi086","article-title":"Adverse effects of antiretroviral therapy in HIV-1 infected children.","volume":"52","author":"Shah","year":"2006","journal-title":"J Trop Pediatr"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1086\/593022","article-title":"Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.","volume":"198","author":"Van Dyke","year":"2008","journal-title":"J Infect Dis"},{"key":"R23-11-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/peds.96.2.247","article-title":"A phase III evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.","volume":"96","author":"Kline","year":"1995","journal-title":"Pediatrics"},{"key":"R24-11-20210130","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe.","volume":"18","year":"2004","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201303130-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T18:01:09Z","timestamp":1643652069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201303130-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835c54b8","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}